Astrid Gnekow

The HIT Network for Children and Adolescents With CNS Tumors Facilitates Improvements of Diagnostic Assessments, Multimodal Treatments, Individual Counseling, and Research in Germany, Austria, and Switzerland

Advancing CNS tumor diagnostics with expanded DNA methylation-based classification

Advancing CNS tumor diagnostics with expanded DNA methylation-based classification

The HIT-network for children and adolescents with CNS tumors facilitates improvements of diagnostic assessments, multimodal treatments, individual counselling, and research in Germany, Austria, and Switzerland

Survivors of infant atypical teratoid/rhabdoid tumors present with severely impaired cognitive functions especially for fluid intelligence and visual processing: data from the German brain tumor studies

Adaption of neurosurgical resection patterns for pediatric low‐grade glioma spanning two decades—Report from the German <scp>LGG</scp> ‐studies 1996–2018

LGG-32. MALIGNANT TRANSFORMATION OF PEDIATRIC LOW-GRADE GLIOMA TO SECONDARY HIGH-GRADE GLIOMA - REPORT FROM THE GERMAN BRAIN TUMOR STUDIES

Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology

Neurosurgical morbidity in pediatric supratentorial midline low‐grade glioma: Results from the German <scp>LGG</scp> studies

Author Correction: Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology

Long-term follow-up of surgical intervention pattern in pediatric low-grade gliomas: report from the German SIOP-LGG 2004 cohort

Integrated molecular and clinical analysis of low-grade gliomas in children with neurofibromatosis type 1 (NF1)

Doubling Recruitment of Pediatric Low-grade Glioma within Two Decades does not change Outcome – Report from the German LGG Studies

LGG-06. COMPREHENSIVE GENOMIC CHARACTERIZATION AND INTEGRATED CLINICAL ANALYSIS OF LOW-GRADE GLIOMAS IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1

Response to trametinib treatment in progressive pediatric low-grade glioma patients

Loss of efficacy of subsequent nonsurgical therapy after primary treatment failure in pediatric low‐grade glioma patients—Report from the German <scp>SIOP‐LGG</scp> 2004 cohort

Long-term cognitive deficits in pediatric low-grade glioma (LGG) survivors reflect pretreatment conditions—report from the German LGG studies

Accurate calling of <i>KIAA1549‐BRAF</i> fusions from DNA of human brain tumours using methylation array‐based copy number and gene panel sequencing data

High frequency of disease progression in pediatric spinal cord low-grade glioma (LGG): management strategies and results from the German LGG study group

Prognostic impact of distinct genetic entities in pediatric diffuse glioma <scp>WHO</scp>‐grade <scp>II</scp>—Report from the German/Swiss <scp>SIOP‐LGG</scp> 2004 cohort

SIOP-E-BTG and GPOH Guidelines for Diagnosis and Treatment of Children and Adolescents with Low Grade Glioma

Health status, health-related quality of life, and socioeconomic outcome in childhood brain tumor survivors: a German cohort study

Natural History of Pediatric Low-Grade Glioma Disease - First Multi-State Model Analysis

Favorable prognosis in pediatric brainstem low‐grade glioma: Report from the German SIOP‐LGG 2004 cohort

Correction: SIOP-E-BTG and GPOH Guidelines for Diagnosis and Treatment of Children and Adolescents with Low Grade Glioma

DNA methylation-based classification of central nervous system tumours

THROMBOTECT – a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents

LGG-48. MULTI-STATE-ANALYSIS FOR PEDIATRIC PATIENTS WITH LOW-GRADE GLIOMA

Childhood cancer predisposition syndromes—A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology

A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report